table of content
1 Introduction to Research & Analysis Reports
1.1 mRNA Vaccines & Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global mRNA Vaccines & Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global mRNA Vaccines & Therapeutics Overall Market Size
2.1 Global mRNA Vaccines & Therapeutics Market Size: 2022 VS 2029
2.2 Global mRNA Vaccines & Therapeutics Revenue, Prospects & Forecasts: 2018-2029
2.3 Global mRNA Vaccines & Therapeutics Sales: 2018-2029
3 Company Landscape
3.1 Top mRNA Vaccines & Therapeutics Players in Global Market
3.2 Top Global mRNA Vaccines & Therapeutics Companies Ranked by Revenue
3.3 Global mRNA Vaccines & Therapeutics Revenue by Companies
3.4 Global mRNA Vaccines & Therapeutics Sales by Companies
3.5 Global mRNA Vaccines & Therapeutics Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 mRNA Vaccines & Therapeutics Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers mRNA Vaccines & Therapeutics Product Type
3.8 Tier 1, Tier 2 and Tier 3 mRNA Vaccines & Therapeutics Players in Global Market
3.8.1 List of Global Tier 1 mRNA Vaccines & Therapeutics Companies
3.8.2 List of Global Tier 2 and Tier 3 mRNA Vaccines & Therapeutics Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global mRNA Vaccines & Therapeutics Market Size Markets, 2022 & 2029
4.1.2 Infectious Disease Vaccines
4.1.3 Cancer Vaccines
4.2 By Type - Global mRNA Vaccines & Therapeutics Revenue & Forecasts
4.2.1 By Type - Global mRNA Vaccines & Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global mRNA Vaccines & Therapeutics Revenue, 2024-2029
4.2.3 By Type - Global mRNA Vaccines & Therapeutics Revenue Market Share, 2018-2029
4.3 By Type - Global mRNA Vaccines & Therapeutics Sales & Forecasts
4.3.1 By Type - Global mRNA Vaccines & Therapeutics Sales, 2018-2023
4.3.2 By Type - Global mRNA Vaccines & Therapeutics Sales, 2024-2029
4.3.3 By Type - Global mRNA Vaccines & Therapeutics Sales Market Share, 2018-2029
4.4 By Type - Global mRNA Vaccines & Therapeutics Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global mRNA Vaccines & Therapeutics Market Size, 2022 & 2029
5.1.2 Infectious Disease
5.1.3 Cancer
5.2 By Application - Global mRNA Vaccines & Therapeutics Revenue & Forecasts
5.2.1 By Application - Global mRNA Vaccines & Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global mRNA Vaccines & Therapeutics Revenue, 2024-2029
5.2.3 By Application - Global mRNA Vaccines & Therapeutics Revenue Market Share, 2018-2029
5.3 By Application - Global mRNA Vaccines & Therapeutics Sales & Forecasts
5.3.1 By Application - Global mRNA Vaccines & Therapeutics Sales, 2018-2023
5.3.2 By Application - Global mRNA Vaccines & Therapeutics Sales, 2024-2029
5.3.3 By Application - Global mRNA Vaccines & Therapeutics Sales Market Share, 2018-2029
5.4 By Application - Global mRNA Vaccines & Therapeutics Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global mRNA Vaccines & Therapeutics Market Size, 2022 & 2029
6.2 By Region - Global mRNA Vaccines & Therapeutics Revenue & Forecasts
6.2.1 By Region - Global mRNA Vaccines & Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global mRNA Vaccines & Therapeutics Revenue, 2024-2029
6.2.3 By Region - Global mRNA Vaccines & Therapeutics Revenue Market Share, 2018-2029
6.3 By Region - Global mRNA Vaccines & Therapeutics Sales & Forecasts
6.3.1 By Region - Global mRNA Vaccines & Therapeutics Sales, 2018-2023
6.3.2 By Region - Global mRNA Vaccines & Therapeutics Sales, 2024-2029
6.3.3 By Region - Global mRNA Vaccines & Therapeutics Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America mRNA Vaccines & Therapeutics Revenue, 2018-2029
6.4.2 By Country - North America mRNA Vaccines & Therapeutics Sales, 2018-2029
6.4.3 US mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.4.4 Canada mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.4.5 Mexico mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe mRNA Vaccines & Therapeutics Revenue, 2018-2029
6.5.2 By Country - Europe mRNA Vaccines & Therapeutics Sales, 2018-2029
6.5.3 Germany mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.5.4 France mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.5.5 U.K. mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.5.6 Italy mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.5.7 Russia mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.5.8 Nordic Countries mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.5.9 Benelux mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia mRNA Vaccines & Therapeutics Revenue, 2018-2029
6.6.2 By Region - Asia mRNA Vaccines & Therapeutics Sales, 2018-2029
6.6.3 China mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.6.4 Japan mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.6.5 South Korea mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.6.6 Southeast Asia mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.6.7 India mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America mRNA Vaccines & Therapeutics Revenue, 2018-2029
6.7.2 By Country - South America mRNA Vaccines & Therapeutics Sales, 2018-2029
6.7.3 Brazil mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.7.4 Argentina mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa mRNA Vaccines & Therapeutics Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa mRNA Vaccines & Therapeutics Sales, 2018-2029
6.8.3 Turkey mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.8.4 Israel mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.8.5 Saudi Arabia mRNA Vaccines & Therapeutics Market Size, 2018-2029
6.8.6 UAE mRNA Vaccines & Therapeutics Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Moderna Therapeutics
7.1.1 Moderna Therapeutics Company Summary
7.1.2 Moderna Therapeutics Business Overview
7.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Major Product Offerings
7.1.4 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales and Revenue in Global (2018-2023)
7.1.5 Moderna Therapeutics Key News & Latest Developments
7.2 CureVac
7.2.1 CureVac Company Summary
7.2.2 CureVac Business Overview
7.2.3 CureVac mRNA Vaccines & Therapeutics Major Product Offerings
7.2.4 CureVac mRNA Vaccines & Therapeutics Sales and Revenue in Global (2018-2023)
7.2.5 CureVac Key News & Latest Developments
7.3 Translate Bio
7.3.1 Translate Bio Company Summary
7.3.2 Translate Bio Business Overview
7.3.3 Translate Bio mRNA Vaccines & Therapeutics Major Product Offerings
7.3.4 Translate Bio mRNA Vaccines & Therapeutics Sales and Revenue in Global (2018-2023)
7.3.5 Translate Bio Key News & Latest Developments
7.4 BioNTech
7.4.1 BioNTech Company Summary
7.4.2 BioNTech Business Overview
7.4.3 BioNTech mRNA Vaccines & Therapeutics Major Product Offerings
7.4.4 BioNTech mRNA Vaccines & Therapeutics Sales and Revenue in Global (2018-2023)
7.4.5 BioNTech Key News & Latest Developments
7.5 Sangamo Therapeutics
7.5.1 Sangamo Therapeutics Company Summary
7.5.2 Sangamo Therapeutics Business Overview
7.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Major Product Offerings
7.5.4 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales and Revenue in Global (2018-2023)
7.5.5 Sangamo Therapeutics Key News & Latest Developments
7.6 Argos Therapeutics
7.6.1 Argos Therapeutics Company Summary
7.6.2 Argos Therapeutics Business Overview
7.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Major Product Offerings
7.6.4 Argos Therapeutics mRNA Vaccines & Therapeutics Sales and Revenue in Global (2018-2023)
7.6.5 Argos Therapeutics Key News & Latest Developments
7.7 In-Cell-Art
7.7.1 In-Cell-Art Company Summary
7.7.2 In-Cell-Art Business Overview
7.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Major Product Offerings
7.7.4 In-Cell-Art mRNA Vaccines & Therapeutics Sales and Revenue in Global (2018-2023)
7.7.5 In-Cell-Art Key News & Latest Developments
7.8 eTheRNA
7.8.1 eTheRNA Company Summary
7.8.2 eTheRNA Business Overview
7.8.3 eTheRNA mRNA Vaccines & Therapeutics Major Product Offerings
7.8.4 eTheRNA mRNA Vaccines & Therapeutics Sales and Revenue in Global (2018-2023)
7.8.5 eTheRNA Key News & Latest Developments
7.9 Ethris
7.9.1 Ethris Company Summary
7.9.2 Ethris Business Overview
7.9.3 Ethris mRNA Vaccines & Therapeutics Major Product Offerings
7.9.4 Ethris mRNA Vaccines & Therapeutics Sales and Revenue in Global (2018-2023)
7.9.5 Ethris Key News & Latest Developments
7.10 Tiba Biotechnology
7.10.1 Tiba Biotechnology Company Summary
7.10.2 Tiba Biotechnology Business Overview
7.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Major Product Offerings
7.10.4 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales and Revenue in Global (2018-2023)
7.10.5 Tiba Biotechnology Key News & Latest Developments
8 Global mRNA Vaccines & Therapeutics Production Capacity, Analysis
8.1 Global mRNA Vaccines & Therapeutics Production Capacity, 2018-2029
8.2 mRNA Vaccines & Therapeutics Production Capacity of Key Manufacturers in Global Market
8.3 Global mRNA Vaccines & Therapeutics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 mRNA Vaccines & Therapeutics Supply Chain Analysis
10.1 mRNA Vaccines & Therapeutics Industry Value Chain
10.2 mRNA Vaccines & Therapeutics Upstream Market
10.3 mRNA Vaccines & Therapeutics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 mRNA Vaccines & Therapeutics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
